Header Logo

Connection

Sara Vesely to Aged

Back to Details
This is a "connection" page, showing publications Sara Vesely has written about Aged.
Sara Vesely
Connection Strength
0.741
Aged
  1. Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency. Transfusion. 2011 Oct; 51(10):2237-43.
    View in: PubMed
    Score: 0.047
  2. Stability and convergent validity of the Physical Activity Scale for the Elderly (PASE). J Sports Med Phys Fitness. 2004 Jun; 44(2):186-92.
    View in: PubMed
    Score: 0.029
  3. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood. 2003 Jul 01; 102(1):60-8.
    View in: PubMed
    Score: 0.027
  4. SIRT3 overexpression and epigenetic silencing of catalase regulate ROS accumulation in CLL cells activating AXL signaling axis. Blood Cancer J. 2021 05 17; 11(5):93.
    View in: PubMed
    Score: 0.024
  5. Incorporation of whole pelvic radiation into treatment of stage IVB cervical cancer: A novel treatment strategy. Gynecol Oncol. 2020 01; 156(1):100-106.
    View in: PubMed
    Score: 0.021
  6. Effect Modification of the Association Between Race and Stage at Colorectal Cancer Diagnosis by Socioeconomic Status. J Public Health Manag Pract. 2019 Sep/Oct; 25 Suppl 5, Tribal Epidemiology Centers: Advancing Public Health in Indian Country for Over 20 Years:S29-S35.
    View in: PubMed
    Score: 0.021
  7. Factors Associated with Treatment Failure and Radiosurgery-Related Edema in WHO Grade 1 and 2 Meningioma Patients Receiving Gamma Knife Radiosurgery. World Neurosurg. 2019 Oct; 130:e558-e565.
    View in: PubMed
    Score: 0.021
  8. The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017. Haematologica. 2019 10; 104(10):2107-2115.
    View in: PubMed
    Score: 0.020
  9. Prospective Evaluation of Multinational Association of Supportive Care in Cancer Risk Index Score for Gynecologic Oncology Patients With Febrile Neutropenia. Am J Clin Oncol. 2019 02; 42(2):138-142.
    View in: PubMed
    Score: 0.020
  10. Personalized Dosing Versus Fixed Dosing of Immune Checkpoint Inhibitors: A Cost Analysis Study. Am J Ther. 2018 Nov/Dec; 25(6):e767-e768.
    View in: PubMed
    Score: 0.020
  11. Consideration of older patients for enrollment in phase 1 clinical trials: Exploring treatment related toxicities and outcomes. Gynecol Oncol. 2018 04; 149(1):28-32.
    View in: PubMed
    Score: 0.019
  12. Diagnosis of thrombotic thrombocytopenic purpura among patients with ADAMTS13 Activity 10%-20. Am J Hematol. 2017 Nov; 92(11):E644-E646.
    View in: PubMed
    Score: 0.018
  13. Outcomes and Prognostic Factors of Resected Salivary Gland Malignancies: Examining a Single Institution's 12-year Experience. Anticancer Res. 2017 09; 37(9):5019-5025.
    View in: PubMed
    Score: 0.018
  14. Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients. Am J Kidney Dis. 2017 Nov; 70(5):686-695.
    View in: PubMed
    Score: 0.018
  15. Rituximab for thrombotic thrombocytopenic purpura: lessons from the STAR trial. Transfusion. 2017 10; 57(10):2532-2538.
    View in: PubMed
    Score: 0.018
  16. Antibiotic prophylaxis for surgical site infections as a risk factor for infection with Clostridium difficile. PLoS One. 2017; 12(6):e0179117.
    View in: PubMed
    Score: 0.018
  17. Impact of Health Care Insurance Status on Treatment Outcomes of Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2017 07; 17(7):450-456.e2.
    View in: PubMed
    Score: 0.018
  18. Pancreatic Cancer: A Survival Analysis Study in Oklahoma. J Okla State Med Assoc. 2016 Jul-Aug; 109(7-8):391-398.
    View in: PubMed
    Score: 0.017
  19. Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2016 06 16; 127(24):3092-4.
    View in: PubMed
    Score: 0.017
  20. Barriers And Motivators for Smoking Cessation in Patients With Systemic Lupus Erythematosus (SLE). J Okla State Med Assoc. 2015 Nov; 108(11):492-9.
    View in: PubMed
    Score: 0.016
  21. Patterns of Care for Localized Breast Cancer in Oklahoma, 2003-2006. Women Health. 2015; 55(8):975-95.
    View in: PubMed
    Score: 0.016
  22. Depression and cognitive impairment following recovery from thrombotic thrombocytopenic purpura. Am J Hematol. 2015 Aug; 90(8):709-14.
    View in: PubMed
    Score: 0.016
  23. Central nervous system metastasis in gynecologic cancer: symptom management, prognosis and palliative management strategies. Gynecol Oncol. 2015 Mar; 136(3):472-7.
    View in: PubMed
    Score: 0.015
  24. Plasma exchange complications in patients treated for thrombotic thrombocytopenia purpura-hemolytic uremic syndrome: 2011 to 2014. Transfusion. 2014 Dec; 54(12):3257-9.
    View in: PubMed
    Score: 0.015
  25. Increased urinary albumin excretion following recovery from thrombotic thrombocytopenic purpura due to acquired ADAMTS13 deficiency. Am J Kidney Dis. 2014 Aug; 64(2):317-8.
    View in: PubMed
    Score: 0.014
  26. Pulmonary involvement in patients with thrombotic thrombocytopenic purpura. Eur J Haematol. 2014 Feb; 92(2):156-63.
    View in: PubMed
    Score: 0.014
  27. Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood. 2013 Sep 19; 122(12):2023-9; quiz 2142.
    View in: PubMed
    Score: 0.014
  28. Inpatient versus outpatient management of neutropenic fever in gynecologic oncology patients: is risk stratification useful? Gynecol Oncol. 2013 Sep; 130(3):411-5.
    View in: PubMed
    Score: 0.014
  29. Prevalence of primary immune thrombocytopenia in Oklahoma. Am J Hematol. 2012 Sep; 87(9):848-52.
    View in: PubMed
    Score: 0.013
  30. Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol. 2011 Sep; 86(9):743-51.
    View in: PubMed
    Score: 0.012
  31. Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol. 2011 May; 86(5):420-9.
    View in: PubMed
    Score: 0.012
  32. The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Am J Hematol. 2010 Mar; 85(3):174-80.
    View in: PubMed
    Score: 0.011
  33. Addendum to corticosteroid side effects and risk for bleeding in immune thrombocytopenic purpura: patient perspectives. Eur J Haematol. 2009 Nov; 83(5):497-8.
    View in: PubMed
    Score: 0.010
  34. Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives. Eur J Haematol. 2009 Sep; 83(3):175-82.
    View in: PubMed
    Score: 0.010
  35. Adjuvant chemotherapy for the "oldest old" ovarian cancer patients: can we anticipate toxicity-related treatment failure in a vulnerable population? Cancer. 2009 Apr 01; 115(7):1472-80.
    View in: PubMed
    Score: 0.010
  36. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med. 2009 Mar 03; 150(5):293-300.
    View in: PubMed
    Score: 0.010
  37. Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura. IV. An additional study of 43 consecutive patients, 2005 to 2008. Transfusion. 2009 Feb; 49(2):392-4.
    View in: PubMed
    Score: 0.010
  38. Soluble form of carbonic anhydrase IX (CAIX) in transitional cell carcinoma of urinary tract. Neoplasma. 2009; 56(4):298-302.
    View in: PubMed
    Score: 0.010
  39. Long-term deficits in health-related quality of life after recovery from thrombotic thrombocytopenic purpura. Transfusion. 2009 Jan; 49(1):118-24.
    View in: PubMed
    Score: 0.010
  40. Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison. Br J Haematol. 2008 May; 141(5):696-707.
    View in: PubMed
    Score: 0.010
  41. Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, 1989 through 2006. Transfusion. 2008 Feb; 48(2):349-57.
    View in: PubMed
    Score: 0.009
  42. Endemic Esherichia coil O157:H7 infections and hemolytic-uremic syndrome in Oklahoma, 2002-2005. J Okla State Med Assoc. 2007 Nov; 100(11):429-33.
    View in: PubMed
    Score: 0.009
  43. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J Thromb Haemost. 2005 Jul; 3(7):1432-6.
    View in: PubMed
    Score: 0.008
  44. Relationships among youth assets and neighborhood and community resources. Health Educ Behav. 2005 Jun; 32(3):380-97.
    View in: PubMed
    Score: 0.008
  45. The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients. J Am Board Fam Pract. 2004 Sep-Oct; 17(5):309-18.
    View in: PubMed
    Score: 0.007
  46. Clinical utility of D-dimer in patients with suspected pulmonary embolism and nondiagnostic lung scans or negative CT findings. Chest. 2004 Mar; 125(3):851-5.
    View in: PubMed
    Score: 0.007
  47. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS. Semin Hematol. 2004 Jan; 41(1):60-7.
    View in: PubMed
    Score: 0.007
  48. Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care. Am J Hematol. 2003 Nov; 74(3):161-9.
    View in: PubMed
    Score: 0.007
  49. Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes. Ann Intern Med. 2001 Dec 18; 135(12):1047-51.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.